Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres

Authors:

Abstract
Telomeres and tumor suppressor protein TP53 (p53) function in genome protection, but a direct role of p53 at telomeres has not yet been described. Here, we have identified non‐canonical p53‐binding sites within the human subtelomeres that suppress the accumulation of DNA damage at telomeric repeat DNA. These non‐canonical subtelomeric p53‐binding sites conferred transcription enhancer‐like functions that include an increase in local histone H3K9 and H3K27 acetylation and stimulation of subtelomeric transcripts, including telomere repeat‐containing RNA (TERRA). p53 suppressed formation of telomere‐associated γH2AX and prevented telomere DNA degradation in response to DNA damage stress. Our findings indicate that p53 provides a direct chromatin‐associated protection to human telomeres, as well as other fragile genomic sites. We propose that p53‐associated chromatin modifications enhance local DNA repair or protection to provide a previously unrecognized tumor suppressor function of p53. Synopsis Binding of p53 to non‐canonical response elements in human subtelomeres confers enhancer‐like activities and correlates with increased telomere stability. Non‐canonical p53 binding sites were identified in the subtelomeres of both human and mouse. Subtelomeric p53 response elements confer transcription activation in vitro and p53‐dependent induction of TERRA, eRNA‐like transcripts, and more distal subtelomeric genes. p53 status correlates with enhanced telomere stability and survival in response to etoposide‐induced DNA damage. Stress‐induced p53 binding to the subtelomere correlates with increased histone acetylation and decreased γH2AX. CRISPR deletion of the p53 response element ameliorates these effects.
Funding Information
  • Norges Idrettshøgskole (RO1CA140652)
  • Norges Idrettshøgskole (F31CA174199)
  • Norges Idrettshøgskole (R01CA102184)
  • Norges Idrettshøgskole (R01CA164864)
  • Norges Idrettshøgskole (F31HG006395)
  • Philadelphia Health Care Trust (R21 CA 177395‐01)
  • Philadelphia Health Care Trust (R21HG007205)
  • Wistar Cancer Center core (P30 CA10815)
  • Commonwealth Universal Research Enhancement Program
  • Pennsylvania Department of Health

This publication has 60 references indexed in Scilit: